Total Funding
27
Total FundingPost-IPO Debt raised
Growth Score
pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
291447
Endonovo Therapeutics is a biotechnology company developing off-the-shelf regenerative products.
Alan Collier: Chairman & CEO
Steven Barnes: SVP of Investor Relations
About the Company
Endonovo Therapeutics is a biotechnology company developing off-the-shelf regenerative products that no longer require the injection of stem cells. Its platform, Cell Free Therapeutics, harnesses the biological secretions of cells to create therapies that can be immediately administered following injuries or to treat acute and chronic diseases. Its
second platform is the development of non-invasive, bioelectronics to stimulate the body's natural repair system to treat injuries and inflammatory diseases.
